654 related articles for article (PubMed ID: 34237133)
21. Functional enrichment analysis of LYSET and identification of related hub gene signatures as novel biomarkers to predict prognosis and immune infiltration status of clear cell renal cell carcinoma.
Chen Y; He J; Jin T; Zhang Y; Ou Y
J Cancer Res Clin Oncol; 2023 Dec; 149(18):16905-16929. PubMed ID: 37740762
[TBL] [Abstract][Full Text] [Related]
22. Crosstalk of disulfidptosis-related subtypes identifying a prognostic signature to improve prognosis and immunotherapy responses of clear cell renal cell carcinoma patients.
Ren L; Liu J; Lin Q; He T; Huang G; Wang W; Zhan X; He Y; Huang B; Mao X
BMC Genomics; 2024 Apr; 25(1):413. PubMed ID: 38671348
[TBL] [Abstract][Full Text] [Related]
23. A prognostic signature based on immune-related genes for cervical squamous cell carcinoma and endocervical adenocarcinoma.
Liu J; Wu Z; Wang Y; Nie S; Sun R; Yang J; Cheng W
Int Immunopharmacol; 2020 Nov; 88():106884. PubMed ID: 32795900
[TBL] [Abstract][Full Text] [Related]
24. Large-scale transcriptome profiles reveal robust 20-signatures metabolic prediction models and novel role of G6PC in clear cell renal cell carcinoma.
Xu WH; Xu Y; Tian X; Anwaier A; Liu WR; Wang J; Zhu WK; Cao DL; Wang HK; Shi GH; Qu YY; Zhang HL; Ye DW
J Cell Mol Med; 2020 Aug; 24(16):9012-9027. PubMed ID: 32567187
[TBL] [Abstract][Full Text] [Related]
25. Identification of an independent immune-genes prognostic index for renal cell carcinoma.
Li G; Wei X; Su S; Wang S; Wang W; Wang Y; Meng X; Xia J; Song N; Qin C
BMC Cancer; 2021 Jun; 21(1):746. PubMed ID: 34187413
[TBL] [Abstract][Full Text] [Related]
26. Development and Validation of a Nine-Redox-Related Long Noncoding RNA Signature in Renal Clear Cell Carcinoma.
Qi-Dong X; Yang X; Lu JL; Liu CQ; Sun JX; Li C; Wang SG
Oxid Med Cell Longev; 2020; 2020():6634247. PubMed ID: 33425212
[TBL] [Abstract][Full Text] [Related]
27. Prognostic implications of Aquaporin 9 expression in clear cell renal cell carcinoma.
Xu WH; Shi SN; Xu Y; Wang J; Wang HK; Cao DL; Shi GH; Qu YY; Zhang HL; Ye DW
J Transl Med; 2019 Nov; 17(1):363. PubMed ID: 31703694
[TBL] [Abstract][Full Text] [Related]
28. Immune-Associated Gene Signatures Serve as a Promising Biomarker of Immunotherapeutic Prognosis for Renal Clear Cell Carcinoma.
Wang Q; Tang H; Luo X; Chen J; Zhang X; Li X; Li Y; Chen Y; Xu Y; Han S
Front Immunol; 2022; 13():890150. PubMed ID: 35686121
[TBL] [Abstract][Full Text] [Related]
29. The Correlation Between the Immune and Epithelial-Mesenchymal Transition Signatures Suggests Potential Therapeutic Targets and Prognosis Prediction Approaches in Kidney Cancer.
Liang J; Liu Z; Zou Z; Tang Y; Zhou C; Yang J; Wei X; Lu Y
Sci Rep; 2018 Apr; 8(1):6570. PubMed ID: 29700419
[TBL] [Abstract][Full Text] [Related]
30. A Two-DNA Methylation Signature to Improve Prognosis Prediction of Clear Cell Renal Cell Carcinoma.
Shi S; Ye S; Wu X; Xu M; Zhuo R; Liao Q; Xi Y
Yonsei Med J; 2019 Nov; 60(11):1013-1020. PubMed ID: 31637882
[TBL] [Abstract][Full Text] [Related]
31. Identification of a glycolysis-related lncRNA prognostic signature for clear cell renal cell carcinoma.
Ma W; Zhong M; Liu X
Biosci Rep; 2021 Aug; 41(8):. PubMed ID: 34402862
[TBL] [Abstract][Full Text] [Related]
32. The Expression and Prognostic Value of Co-stimulatory Molecules in Clear Cell Renal Cell Carcinoma (CcRcc).
Wu C; Cai X; He C
Comb Chem High Throughput Screen; 2024; 27(2):335-345. PubMed ID: 37171001
[TBL] [Abstract][Full Text] [Related]
33. Crosstalk Between Metabolism and Immune Activity Reveals Four Subtypes With Therapeutic Implications in Clear Cell Renal Cell Carcinoma.
Wang Y; Zheng XD; Zhu GQ; Li N; Zhou CW; Yang C; Zeng MS
Front Immunol; 2022; 13():861328. PubMed ID: 35479084
[TBL] [Abstract][Full Text] [Related]
34. Identification and Comprehensive Validation of a DNA Methylation-Driven Gene-Based Prognostic Model for Clear Cell Renal Cell Carcinoma.
Zhang D; Wang Y; Hu X
DNA Cell Biol; 2020 Oct; 39(10):1799-1812. PubMed ID: 32716214
[TBL] [Abstract][Full Text] [Related]
35. Identifying and Validating an Acidosis-Related Signature Associated with Prognosis and Tumor Immune Infiltration Characteristics in Pancreatic Carcinoma.
Tang P; Qu W; Wu D; Chen S; Liu M; Chen W; Ai Q; Tang H; Zhou H
J Immunol Res; 2021; 2021():3821055. PubMed ID: 34993253
[TBL] [Abstract][Full Text] [Related]
36. Identification of microenvironment-related genes with prognostic value in clear cell renal cell carcinoma.
Zhang Z; Li Z; Liu Z; Zhang X; Yu N; Xu Z
J Cell Biochem; 2020 Jul; 121(7):3606-3615. PubMed ID: 31961022
[TBL] [Abstract][Full Text] [Related]
37. An eleven metabolic gene signature-based prognostic model for clear cell renal cell carcinoma.
Wu Y; Wei X; Feng H; Hu B; Liu B; Luan Y; Ruan Y; Liu X; Liu Z; Wang S; Liu J; Wang T
Aging (Albany NY); 2020 Nov; 12(22):23165-23186. PubMed ID: 33221754
[TBL] [Abstract][Full Text] [Related]
38. Identification and validation of novel prognostic markers in Renal Cell Carcinoma.
Rabjerg M
Dan Med J; 2017 Oct; 64(10):. PubMed ID: 28975890
[TBL] [Abstract][Full Text] [Related]
39. TEK is a novel prognostic marker for clear cell renal cell carcinoma.
Ha M; Son YR; Kim J; Park SM; Hong CM; Choi D; Kang W; Kim JH; Lee KJ; Park D; Han ME; Oh SO; Lee D; Kim YH
Eur Rev Med Pharmacol Sci; 2019 Feb; 23(4):1451-1458. PubMed ID: 30840266
[TBL] [Abstract][Full Text] [Related]
40. Immune classification of clear cell renal cell carcinoma.
Su S; Akbarinejad S; Shahriyari L
Sci Rep; 2021 Feb; 11(1):4338. PubMed ID: 33619294
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
